Abstract
1990 Reusz and his colleagues reported that hyperoxaluria during phosphate supplementation in XLH might contribute to the development of nephrocalcinosis in this discorder. We analysed 18 random urine samples from 11 children with XLH (age:3.0-11.0 years) who were treated with 1-4g elemental phosphorus/day, given in four to six single doses, and 30-60 ng 1.25(OH)2D3/kg/day given in two divided doses. There were no signs of severe nephrocalcinosis or renal stones. Urines were collected at about 9 AM after an overnight fast and after the bladder was emptied at about 6 AM. Oxalate excretion was analysed by a enzymatic method and the results were compared with oxalate excretion in random urines from 19 healthy children (age: 4.0-17.0 years).
The oxalate excretion was significantly higher (< 0.01) in XLH (15,9-187,2 μg/mg creatinine) compared to our control group (1,3-27 μg/mg crea).
There was a positive relationship between the oxalate and phosphate excretion, both values being relative to creatinine excretion (r = 0.71p < 0.01).
In conclusion, we found an elevated oxalate excreuon in patients with XLH with appears to be dependent on the phosphate excretion, which in turn is known to be dependent on phosphate intake in XLH. Further long-term studies are necessary to determine whether hyperoxaluria is of clinical relevance for development of nephrocalcinosis in XLH.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schönau, E., Cagnoli, M., Böhles, H. et al. Hyperoxaluria in Phosphate-Treated X-linked Familial Hypophosphataemic Rickets (XLH). Pediatr Res 32, 628 (1992). https://doi.org/10.1203/00006450-199211000-00139
Issue Date:
DOI: https://doi.org/10.1203/00006450-199211000-00139